Evidence map›Paper›PMID 35373038›Full record

ArticleKidney3602021

Center-Effect of Incident Hemodialysis Vascular Access Use: Analysis of a Bi-national Registry.

Samantha Ng, Elaine M Pascoe, David W Johnson, Carmel M Hawley, Kevan R Polkinghorne, Stephen McDonald, Philip A Clayton, Kannaiyan S Rabindranath, Matthew A Roberts, Ashley B Irish and 1 more

Open access · diamondAbstract read
In one paragraph

Article in Kidney360, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.8field-weighted citation impact, top 28% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 3 citations in OpenAlex.

  1. Article
  2. Article
  3. Epidemiology of haemodialysis outcomes.Nature reviews. Nephrology · 2022
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 9 institutions in 2 countries.

Samantha NgDepartment of Nephrology, Princess Alexandra Hospital, Brisbane, Australia.
Elaine M PascoeAustralasian Kidney Trials Network, Faculty of Medicine, University of Queensland, Brisbane, Australia.
David W JohnsonDepartment of Nephrology, Princess Alexandra Hospital, Brisbane, Australia.
Carmel M HawleyDepartment of Nephrology, Princess Alexandra Hospital, Brisbane, Australia.
Kevan R PolkinghorneDepartment of Nephrology, Monash Medical Center, Melbourne, Australia.
Stephen McDonaldAustralia and New Zealand Dialysis and Transplant (ANZDATA) Registry, South Australian Health and Medical Research Institute, Adelaide, Australia.
Philip A ClaytonAustralia and New Zealand Dialysis and Transplant (ANZDATA) Registry, South Australian Health and Medical Research Institute, Adelaide, Australia.
Kannaiyan S RabindranathRenal Unit, Waikato District Hospital, Hamilton, New Zealand.
Matthew A RobertsAustralia and New Zealand Dialysis and Transplant (ANZDATA) Registry, South Australian Health and Medical Research Institute, Adelaide, Australia.
Ashley B IrishMedical School, University of Western Australia, Perth, Australia.
Andrea K ViecelliDepartment of Nephrology, Princess Alexandra Hospital, Brisbane, Australia.
Australia and New Zealand Dialysis and Transplant Registry · AUKidney Health Australia · AUEastern Health · AUFiona Stanley Hospital · AUMonash University · AUPrincess Alexandra Hospital · AUThe University of Queensland · AUTranslational Research Institute · AUWaikato Hospital · NZ

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Commencing hemodialysis (HD) with an arteriovenous access is associated with superior patient outcomes compared with a catheter, but the majority of patients in Australia and New Zealand initiate HD with a central venous catheter. This study examined patient and center factors associated with arteriovenous fistula/graft access use at HD commencement. Methods: We included all adult patients starting chronic HD in Australia and New Zealand between 2004 and 2015. Access type at HD initiation was analyzed using logistic regression. Patient-level factors included sex, age, race, body mass index (BMI), smoking status, primary kidney disease, late nephrologist referral, comorbidities, and prior RRT. Center-level factors included size; transplant capability; home HD proportion; incident peritoneal dialysis (average number of patients commencing RRT with peritoneal dialysis per year); mean weekly HD hours; average blood flow; and achievement of phosphate, hemoglobin, and weekly Kt/V targets. The study included 27,123 patients from 61 centers. Results: Arteriovenous access use at HD commencement varied four-fold from 15% to 62% (median 39%) across centers. Incident arteriovenous access use was more likely in patients aged 51-72 years, males, and patients with a BMI of >25 kg/m Conclusions: This study identified several patient and center factors associated with incident HD access use, yet these factors did not fully explain the substantial variability in arteriovenous access use across centers.

Indexed as

Kidney Failure, ChronicPeritoneal DialysisAdultAgedHemodialysis, HomeHumansMaleMiddle AgedRegistriesRenal Dialysisarteriovenous accessarteriovenous fistulacenter characteristicscenter effectcenter sizecenter variationcentral venous catheterdialysishemodialysisvascular access

Identifiers

PMID35373038
PMCPMC8791318
OpenAlexW3128573163

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.